We engineer bespoke sgRNA/shRNA libraries targeting specific gene families or pathways, optimized for your model's unique genetic background and screening objectives.
CRISPR/RNAi Functional Screening Service for Metastasis Regulator
Creative Biolabs provides an advanced functional genomics platform dedicated to identifying the molecular mechanisms driving cancer metastasis in research models. Our clients gain access to a streamlined discovery engine that combines custom CRISPR/RNAi libraries with sophisticated surgical animal models and expert bioinformatics. By partnering with us, research teams obtain actionable candidate gene lists and validated data that clarify the transition from primary tumors to systemic colonization, effectively de-risking early-stage discovery and highlighting novel therapeutic nodes within the metastatic cascade.
Introduction What We Can Offer How We Can Help Why Choose Us Customer Reviews FAQs Related Services Contact Us
Advancing Metastasis Research via High-Throughput Functional Screening
Metastasis is an inefficient but lethal process requiring cells to adapt to diverse stressors. Established research demonstrates that functional genomics - specifically CRISPR and RNAi - is a powerful tool to establish causality in this complex cascade. By comparing isogenic lines and utilizing iteratively selected research models, investigators can now isolate genes required for niche survival rather than simple fitness. Creative Biolabs integrates these findings into a commercial platform that delivers actionable targets for academic and industrial discovery.
Request a Consultation →
Fig.1 CRISPR screen tools and workflow. 1
What We Can Offer
Fully Customized Library Design
Iteratively Selected "High-Penetrance" Models
We utilize cell lines pre-conditioned through serial passage to maximize metastatic potential, ensuring robust data and minimal experimental variability.
One-Stop Surgical Expertise
Our specialists perform complex orthotopic implantations in various organs, replicating the natural tumor environment and the complete biological invasion-metastasis cascade.
High-Coverage "Bottleneck" Management
We prioritize statistical power by maintaining strict construct coverage, preventing the loss of library representation during systemic dissemination in research animals.
How Creative Biolabs Can Assist Your Project
Highlights
Integrated Oncology Expertise
Creative Biolabs operates at the unique intersection of advanced functional genomics and specialized surgical oncology to provide unparalleled metastatic research insights.
Iterative Selection Technology
We utilize cell lines pre-conditioned for high metastatic penetrance, effectively minimizing experimental noise and enhancing the reliability of target identification.
Differential Essentiality Screening
Our platform identifies genetic targets vital only to metastatic cells, ensuring identified vulnerabilities are highly specific while sparing healthy host tissues.
Evidence-Based Protocols
Our methodologies are meticulously aligned with established research benchmarks, ensuring that your study adheres to the most rigorous scientific standards.
Reach out to our experts to accelerate your lead optimization with data that bridges the gap between mechanical theory and therapeutic success.
Customer Reviews
-
Unparalleled In Vivo Representation
Creative Biolabs' pooling strategies effectively mitigated library dropouts, preserving construct diversity across distal sites and facilitating the identification of subtle metabolic regulators previously masked by stochastic noise. - Dr. E**a. V. -
Recapitulating the Metastatic Niche
Creative Biolabs' orthotopic models and surgical expertise facilitate the identification of causal drivers within authentic microenvironments. This platform remains essential for investigators dissecting the complexities of metastatic progression. - Dr. S**h. L.
FAQs
How do you ensure the library doesn't get lost during the 'metastatic bottleneck'?
We utilize refined libraries (sub-pools) and high-coverage injection protocols to ensure that stochastic loss of cells doesn't lead to false negatives in the metastatic nodules.
Can you screen for organ-specific metastasis?
Yes. We utilize specialized orthotopic and systemic models paired with niche-specific harvesting to isolate genes required for crossing barriers or colonizing specific tissues in research animals.
Related Services
Adhesion & Organotropism Receptor-Ligand Profiling
We provide high-resolution analysis of actin-myosin contractility and focal adhesion dynamics to characterize shifting invasion phenotypes in complex microenvironments.
Learn More →Microfluidic Anti-Invasion Compound Test Service
This service utilizes biomimetic microchannels to quantify the inhibitory potential of candidate molecules against trans-endothelial migration and invasive interstitial trafficking.
Learn More →How to Contact Us
Creative Biolabs provides an advanced CRISPR/RNAi functional screening service for metastasis regulator for the research community. From high-density library design to sophisticated orthotopic modeling and public data correlation, we provide the insights you need to target the most aggressive stages of cancer progression.
To evaluate project feasibility or obtain a customized budgetary quotation, we invite you to contact our team.
Reference
- Shen, Wanying et al. "Applications of CRISPR screening to lung cancer treatment." Frontiers in cell and developmental biology vol. 11 1295555. 15 Dec. 2023. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fcell.2023.1295555
Download our brochureLoading case studies...
Online Inquiry